Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX)

CUSIP: 03168L105

Q3 2026 13F Holders as of 30 Sep 2026

Holder snapshot 6 signals
Share change
+757,890
SEC-reported price per share
$20.14
Number of holders
14
Value change
+$15,263,904
Number of buys
7
Number of sells
1
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
348,532,261

Security key

03168L105

Report period

Q3 2026

Institutions

14

Top holders

10

Ownership snapshot

Top reported holders of AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Tushar Bhikhubhai Patel
Disclosed value leader
Tushar Bhikhubhai Patel
Comparable rows
15/15
Latest evidence
10 Aug 2026
3/4/5 13D/G 13F Lead comparable stake: 18% 13D/G row: Tushar Bhikhubhai Patel Showing 1-6 of 15 holder rows.

Quick read

Tushar Bhikhubhai Patel leads the comparable SEC ownership view at 18%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Tushar Bhikhubhai Patel's linked filing trail.
Comparable ownership Top 5
Tushar Bhikhubhai Patel 18%
Chintu Patel 9.4%
Chirag K. Patel 8.4%
Akram Mahesh 6.6%
Dipan Patel 5.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Tushar Bhikhubhai Patel
3/4/5 13D/G
10%+ Owner · Tushar Patel
18%
from 13D/G
$1,467,452,491
109,919,887 shares
mixed-class rows
— 10 Aug 2026
Chintu Patel
3/4/5 13D/G
Co-CEO, Director
9.4%
from 13D/G
$573,308,687
32,708,692 shares
mixed-class rows
— 10 Aug 2026
Chirag K. Patel
3/4/5 13D/G
President & Co-CEO, Director · Chirag Patel
8.4%
from 13D/G
$513,089,222
29,229,809 shares
mixed-class rows
— 10 Aug 2026
Akram Mahesh
13D/G
6.6%
$153,779,517
20,558,759 shares
$0 31 Mar 2025
Dipan Patel
13D/G 3/4/5
Patel Dipan · Member of 13D Group
5.4%
$244,942,771
16,904,263 shares
-$100,339,323 31 Dec 2025
VANGUARD GROUP INC
13D/G
The Vanguard Group
5%
$117,905,198
15,762,727 shares
$0 31 Mar 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
14
Shares
1,770,488
Rows available
14
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders
308
Q3 2026 holders
14
Holder diff
-294
Investor Q2 2026 Shares Q3 2026 Shares Share Diff Share Chg % Q2 2026 value Q3 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .